A first-of-its-kind congressional committee hearing took place on Thursday, with lawmakers examining the impacts of Food and Drug Administration (FDA) inaction on developing regulations to allow for the sale of hemp-derived CBD as food items or dietary supplements. The House Oversight and Accountability Subcommittee on Health Care and Financial Services announced the scheduling of the … Continue reading Congressional Committee Addresses FDA Inaction On CBD Regulations At Hearing